Intelligene Inc. (TPEX:7832)
Taiwan · Delayed Price · Currency is TWD 15.20
-0.55 (-3.49%)
At close: Jan 19, 2026
Intelligene Company Description
Intelligene Inc. engages in the research and development of RNA gene therapy drugs in Taiwan and Australia.
The company offers IG-001, a siRNA-based drug which is under preclinical trials for the treatment of coronavirus disease; and IG-002, a siRNA-based drug which is under drug screening for the treatment of influenza.
It also provides lipid nanoparticle and exosome drug encapsulation technologies to customize drug carriers and develop nucleic acid therapeutics.
The company was founded in 2023 and is based in Taipei, Taiwan.
Intelligene Inc.
| Country | Taiwan |
| Founded | 2023 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 20 |
| CEO | Xianlong Huang |
Contact Details
Address: 14F-6, No. 508, Section 7 Taipei Taiwan | |
| Phone | 886 2 2655 8825 |
| Website | intelli-gene.com |
Stock Details
| Ticker Symbol | 7832 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Xianlong Huang | Chief Executive Officer |
| Shixian Huang | Chief Financial Officer |
| Peiyi Song | Chief Operating Officer |